Yuhan Corporation's new lung cancer drug "Leklaza" is looking to become a blockbuster, achieving 440 billion won in sales in ...

Kakao founder Kim Bum-soo, who is undergoing cancer treatment, recently underwent surgery again due to the recurrence of ...

Following Verzenio (abemaciclib), Kisqali (ribociclib) will likely become available in Korea as an endocrine and adjuvant ...

Pin Therapeutics announced on Friday that it has signed a strategic memorandum of understanding with ImpriMed, a company ...

Cure-in Inc. (co-CEOs Yung-Ho Jo and Samuel Byeongjun Park), a medical robotics company founded in 2020 by a research team ...

Ongoing conflict between the government and the medical community has led to delays in treatment and surgery for many cancer patients. However, research has shown that if surgery for early-stage breas ...

(Seoul=Yonhap Infomax) Yun Gu Lee – Hanwha Life Insurance Co., a leading South Korean insurer, announced on the 16th that it ...

Actor Kang Seo-ha (real name: Kang Ye-won) has died after a battle with stomach cancer, at the age of 31. According to a ...

암 치료를 위한 항암화학요법이 ‘잠자는 암세포’를 깨워 다른 장기로의 ‘전이’를 촉진할 수 있다는 충격적인 연구 결과가 나왔다. 중국과학원(CAS) 산하 상하이 영양과학연구소 등은 3일(현지시간) 종양학 분야 국제학술지 ...

IBA는 전 세계 입자치료기 시장을 선도하고 있는 글로벌 기업으로, 이번 협상을 통해 창원한마음병원에 최신 입자치료 기술인 다이나믹아크 (DynamicARC) 기술이 탑재된 양성자 치료기 도입에 상호 협력을 약속했다.

On July 15, Korean biotech companies drew strong investor attention on the back of progress in new drug development and ...

정밀 종양학 기업 가던트 헬스(Guardant Health)의 혈액 기반 대장암 선별검사 ‘쉴드(Shield)’가 미국 종합 암 치료 권위기관인NCCN(National Comprehensive Cancer Network) ...